Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Revenue (2021 - 2025)

ProQR Therapeutics' Revenue history spans 5 years, with the latest figure at $5.5 million for Q4 2025.

  • On a quarterly basis, Revenue rose 18.57% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.9 million, a 12.45% decrease, with the full-year FY2025 number at $18.5 million, down 8.35% from a year prior.
  • Revenue hit $5.5 million in Q4 2025 for ProQR Therapeutics, up from $3.4 million in the prior quarter.
  • Over the last five years, Revenue for PRQR hit a ceiling of $6.8 million in Q2 2024 and a floor of $273409.1 in Q4 2021.
  • Historically, Revenue has averaged $2.7 million across 5 years, with a median of $1.5 million in 2023.
  • Biggest five-year swings in Revenue: crashed 44.57% in 2023 and later surged 587.63% in 2024.
  • Tracing PRQR's Revenue over 5 years: stood at $273409.1 in 2021, then soared by 168.67% to $734578.1 in 2022, then surged by 381.01% to $3.5 million in 2023, then soared by 30.26% to $4.6 million in 2024, then grew by 18.57% to $5.5 million in 2025.
  • Business Quant data shows Revenue for PRQR at $5.5 million in Q4 2025, $3.4 million in Q3 2025, and $4.3 million in Q2 2025.